Signal2026-08-11
ClinicalTrials.gov

[PHASE1] A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension

Part of

Dynamic Medicine And Treatment Timing

Open primary sourceRead on Substack